Senores Pharmaceuticals Ltd. (SENORES) Financial Statements

1 Followers

Senores Pharmaceuticals Ltd. Financial Overview

Senores Pharmaceuticals Ltd.'s market cap is currently ₹51.14B. The company's EPS TTM is ₹6.54; its P/E ratio is 28.18; Senores Pharmaceuticals Ltd. is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 25
Income Statement
Total Revenue	₹ 3.83B	₹ 6.33B
Gross Profit	₹ 14.11M	₹ 3.81B
Operating Income	₹ 728.10M	₹ 1.37B
EBITDA	₹ 1.08B	₹ 2.15B
Net Income	₹ 6.85M	₹ 1.15B
Balance Sheet
Cash & Short-Term Investments	₹ 3.85B	₹ 3.32B
Total Assets	₹ 145.66M	₹ 16.04B
Total Debt	₹ 3.15B	₹ 3.42B
Net Debt	₹ 24.48M	₹ 2.96B
Total Liabilities	₹ 50.70M	₹ 6.39B
Stockholders' Equity	₹ 7.86B	₹ 9.34B
Cash Flow
Free Cash Flow	₹ -2.03B	₹ -2.03B
Operating Cash Flow	₹ -459.20M	₹ 620.50M
Investing Cash Flow	₹ -4.29B	₹ -1.21B
Financing Cash Flow	₹ 5.73B	₹ -13.30M

Currency in INR

Senores Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Senores Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Senores Pharmaceuticals Ltd. Cash Flow

Cash Flow >

Senores Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >